Articles & Resources

Cell Therapy

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Cell Therapy

Clear filter

Meeting the Cell Therapy Cost Challenge with Automation

Peter Olagunju (bluebird bio), Rodney Rietze (Novartis) and Dieter Hauwaerts (Celyad) discuss how to achieve cost-effective therapies through automation.

INTERVIEW SERIES: Strategies for Success in Cell & Advanced Therapies

Read interviews with cell therapy industry leaders for their perspectives on obtaining funding, regulatory considerations and scaling manufacturing

Manufacturing & Scalability Considerations for Cell Therapies

Leading experts in cell and advanced therapy manufacturing planning and technology offer their insights in Part 3 of our Cell Therapy Interview Series.

The Evolving Regulatory Climate for Cell & Advanced Therapies

Invetech invited experts in regulatory affairs to share their insights and offer guidance on how to keep clinical development programs moving forward.

Funding & Financing Considerations for Cell Therapy Companies

Leaders in investment and corporate finance share their perspectives on financing challenges and opportunities for cell and advanced therapy companies.

Factors Influencing Cell Therapy Automation Decisions

In an interview with BioInsights, Brian Hanrahan discusses the factors influencing automation decisions in cell and advanced therapy manufacture.

The Bright Future of European Regenerative Medicine

Our key takeaways from the 2016 World Stem Cells & Regenerative Medicine Congress.

How Cell Therapy Can Revolutionize Healthcare

Invetech Marketing Manager Alan Morris relays the insights he gained at the 2016 Phacilitate Cell & Gene Therapy World conference in Washington, D.C.

Considerations for Cell Therapies Achieving Commercial Success

CCRM, bluebird bio and Invetech discuss the key considerations for achieving commercial success for cell therapies. Read a recap of this webinar hosted by ISCT.

GUIDE: Planning for Commercial Success of Cell and Advanced Therapies

In this white paper, we detail the 5 key elements essential to successfully moving cell and advanced therapies from the clinic to commercial-scale production.

WHITE PAPER: Manufacturing Cell Therapiesā€”Development Strategies for Commercial Vision

In this white paper, Invetech and PCT share insights on how to address the unique challenges faced when developing and manufacturing a patient-specific cell therapy (PSCT).